| pubmed-article:14534879 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14534879 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:14534879 | lifeskim:mentions | umls-concept:C0543467 | lld:lifeskim |
| pubmed-article:14534879 | lifeskim:mentions | umls-concept:C0017471 | lld:lifeskim |
| pubmed-article:14534879 | lifeskim:mentions | umls-concept:C0007097 | lld:lifeskim |
| pubmed-article:14534879 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:14534879 | lifeskim:mentions | umls-concept:C0041365 | lld:lifeskim |
| pubmed-article:14534879 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
| pubmed-article:14534879 | lifeskim:mentions | umls-concept:C0442967 | lld:lifeskim |
| pubmed-article:14534879 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
| pubmed-article:14534879 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:14534879 | pubmed:dateCreated | 2003-10-9 | lld:pubmed |
| pubmed-article:14534879 | pubmed:abstractText | A standard concept for the integration of surgery into the chemotherapy-based treatment of patients with advanced germ cell carcinoma has been that surgery should be avoided in patients with serum tumor markers (alpha-fetoprotein [AFP] and human chorionic gonadotropin [HCG]) that remain elevated. However, some patients may benefit from resection under such chemorefractory conditions. The objective of this retrospective study was to clarify the outcome and clinical prognostic variables of salvage surgery in patients with disseminated (AJCC Stage II or III) testicular germ cell carcinoma or extragonadal germ cell carcinoma who had elevated serum markers. | lld:pubmed |
| pubmed-article:14534879 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14534879 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14534879 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:14534879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14534879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14534879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14534879 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14534879 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:14534879 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:14534879 | pubmed:author | pubmed-author:OgawaOsamuO | lld:pubmed |
| pubmed-article:14534879 | pubmed:author | pubmed-author:OkuyamaAkihik... | lld:pubmed |
| pubmed-article:14534879 | pubmed:author | pubmed-author:AkazaHideyuki... | lld:pubmed |
| pubmed-article:14534879 | pubmed:author | pubmed-author:KobayashiTaka... | lld:pubmed |
| pubmed-article:14534879 | pubmed:author | pubmed-author:KamidonoSadao... | lld:pubmed |
| pubmed-article:14534879 | pubmed:author | pubmed-author:HaraIsaoI | lld:pubmed |
| pubmed-article:14534879 | pubmed:author | pubmed-author:MikiTsuneharu... | lld:pubmed |
| pubmed-article:14534879 | pubmed:author | pubmed-author:KatoTetsuroT | lld:pubmed |
| pubmed-article:14534879 | pubmed:author | pubmed-author:HabuchiTomono... | lld:pubmed |
| pubmed-article:14534879 | pubmed:author | pubmed-author:KamotoToshiyu... | lld:pubmed |
| pubmed-article:14534879 | pubmed:author | pubmed-author:NonomuraNorio... | lld:pubmed |
| pubmed-article:14534879 | pubmed:author | pubmed-author:KawaiKojiK | lld:pubmed |
| pubmed-article:14534879 | pubmed:author | pubmed-author:NakaoMasahiro... | lld:pubmed |
| pubmed-article:14534879 | pubmed:copyrightInfo | Copyright 2003 American Cancer Society. | lld:pubmed |
| pubmed-article:14534879 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14534879 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:14534879 | pubmed:volume | 98 | lld:pubmed |
| pubmed-article:14534879 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14534879 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14534879 | pubmed:pagination | 1635-42 | lld:pubmed |
| pubmed-article:14534879 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:14534879 | pubmed:meshHeading | pubmed-meshheading:14534879... | lld:pubmed |
| pubmed-article:14534879 | pubmed:meshHeading | pubmed-meshheading:14534879... | lld:pubmed |
| pubmed-article:14534879 | pubmed:meshHeading | pubmed-meshheading:14534879... | lld:pubmed |
| pubmed-article:14534879 | pubmed:meshHeading | pubmed-meshheading:14534879... | lld:pubmed |
| pubmed-article:14534879 | pubmed:meshHeading | pubmed-meshheading:14534879... | lld:pubmed |
| pubmed-article:14534879 | pubmed:meshHeading | pubmed-meshheading:14534879... | lld:pubmed |
| pubmed-article:14534879 | pubmed:meshHeading | pubmed-meshheading:14534879... | lld:pubmed |
| pubmed-article:14534879 | pubmed:meshHeading | pubmed-meshheading:14534879... | lld:pubmed |
| pubmed-article:14534879 | pubmed:meshHeading | pubmed-meshheading:14534879... | lld:pubmed |
| pubmed-article:14534879 | pubmed:meshHeading | pubmed-meshheading:14534879... | lld:pubmed |
| pubmed-article:14534879 | pubmed:meshHeading | pubmed-meshheading:14534879... | lld:pubmed |
| pubmed-article:14534879 | pubmed:meshHeading | pubmed-meshheading:14534879... | lld:pubmed |
| pubmed-article:14534879 | pubmed:meshHeading | pubmed-meshheading:14534879... | lld:pubmed |
| pubmed-article:14534879 | pubmed:meshHeading | pubmed-meshheading:14534879... | lld:pubmed |
| pubmed-article:14534879 | pubmed:meshHeading | pubmed-meshheading:14534879... | lld:pubmed |
| pubmed-article:14534879 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14534879 | pubmed:articleTitle | Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers. | lld:pubmed |
| pubmed-article:14534879 | pubmed:affiliation | Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan. | lld:pubmed |
| pubmed-article:14534879 | pubmed:publicationType | Journal Article | lld:pubmed |
